Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-16T20:20:48.297Z Has data issue: false hasContentIssue false

Relationship between the consumption of dairy foods and markers of glycaemic control: evidence from the Caerphilly prospective cohort study

Published online by Cambridge University Press:  08 March 2023

Y. Chatzidiakou
Affiliation:
Hugh Sinclair Unit of Human Nutrition, and Institute for Cardiovascular and Metabolic Research, Department of Food and Nutritional Science, University of Reading, Reading, UK Institute of Food, Nutrition and Health Institute of Cardiovascular and Metabolic Research, University of Reading, UK
K. G. Jackson
Affiliation:
Hugh Sinclair Unit of Human Nutrition, and Institute for Cardiovascular and Metabolic Research, Department of Food and Nutritional Science, University of Reading, Reading, UK Institute of Food, Nutrition and Health Institute of Cardiovascular and Metabolic Research, University of Reading, UK
J. A. Lovegrove
Affiliation:
Hugh Sinclair Unit of Human Nutrition, and Institute for Cardiovascular and Metabolic Research, Department of Food and Nutritional Science, University of Reading, Reading, UK Institute of Food, Nutrition and Health Institute of Cardiovascular and Metabolic Research, University of Reading, UK
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2023

Evidence from large prospective cohort studies suggests that dairy consumption has a neutral or moderately beneficial effect on type 2 diabetes (T2D) risk(Reference Guo, Givens and Astrup1), but the effect of different types of dairy foods remains uncertain(Reference Soedamah-Muthu and De Goede2). The aim of the present study was to investigate the cross-sectional and the prospective association between total dairy, milk, cheese, cream and butter consumption and markers of glycaemic control.

Analysis was performed at baseline and after a 5-year follow-up using data from the Caerphilly Prospective Cohort study (CAPs)(3) which included 2512 men aged 45–59 years, who were free of cardiovascular diseases, T2D, and cancer at baseline, and followed up at 5-year intervals for over 20- years. A semi-quantitative food frequency questionnaire estimated the intake of foods and nutrients. In total, 1350 men with available dietary, anthropometric, glucose and insulin data were included in the current analysis. ANOVA and Chi-square tests determined differences in nutrient intakes and other characteristics at baseline when data were stratified according to quartiles of total dairy intake. Cross-sectional analysis was conducted at baseline using a one-way ANOVA (unadjusted data) and analysis of variance with covariates (ANCOVA), adjusted for reported confounders of the relationship between dairy and glycaemic control in three separate gradually adjusted models. For the longitudinal analysis, ANOVA (unadjusted data) was performed to investigate the change after a 5-year follow-up from baseline in serum glucose, insulin, and estimates of insulin resistance. For the longitudinal analysis the ANCOVA was corrected for the covariates (age, BMI, and total energy intake) at baseline in separate progressively adjusted models and was further adjusted for the baseline outcome of interest.

The mean ± SD intake of milk, cheese, cream, and butter in the cohort was 289 ± 182 g/d, 18.4 ± 12.4 g/d, 1.8 ± 3.8 g/d and 24.7 ± 19.9 g/d respectively. At baseline, subjects in the highest quartile of total dairy intake were significantly more likely to be smokers, drank less alcohol, had a higher total energy intake, and consumed more protein, fat, sugar, and eggs compared to individuals in the lowest quartile (P < 0.05). No associations were observed between the levels of total dairy, milk, cheese, cream, or butter consumption cross-sectionally as well as changes in plasma glucose, insulin, and indices of insulin resistance after a 5-year follow-up. Correcting for covariates did not impact these relationships.

A neutral effect of total dairy and types of dairy product intake on markers of glycaemic control was observed. More suitably powered human prospective cohort studies with longer periods of follow up are needed in healthy and at-risk UK populations to interpret the role of both the amount and type of dairy on measures of glycaemic control and the underlying mechanisms involved.

Acknowledgments

We thank Professor Yoav Ben-Shlomo, School of Social and Community Medicine, University of Bristol for managing the release of data from the CAPs and acknowledge valuable support from Professor Peter C. Elwood, University of Cardiff and Andrew D. Beswick, University of Bristol for their assistance and guidance regarding to the terms and units used for glucose and insulin. We also thank Dr (Sarah) Jing Guo for her invaluable and consistent advice with regards to the Caerphilly Prospective Cohort Study dataset use.

References

Guo, J, Givens, DI, Astrup, A, et al. (2019) Adv Nutr 10, 10661075.CrossRefGoogle Scholar
Soedamah-Muthu, SS & De Goede, J (2018) Curr Nutr Rep 7, 171182.CrossRefGoogle Scholar
The Caerphilly and Speedwell Collaborative Group. Caerphilly and Speedwell collaborative heart disease studies. (1984) J Epidemiol Community Health 259262.Google Scholar